Infusion and chronic care management company Uptiv Health announced a partnership with the automation platform Lamar Health to implement AI-powered automation for referral intake and prior authorization processes. Uptiv offers infusion therapy for patients with chronic conditions via a hybrid model that merges customized in-clinic care with a digital platform. In addition to traditional infusion…
Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable. Nanowear offers home-based, AI-enabled digital diagnostics for cardiometabolic health. The company’s FDA-cleared SimpleSense wearable reads patient vitals, such as respiration rate, heart rate, blood pressure, physical…
Health technology company Royal Philips has expanded its partnership with Ibex Medical Analytics that includes a new release of Philips IntelliSite Pathology Solution (PIPS) to speed up adoption of AI-enabled digital pathology tools. In 2021, Philips and Ibex combined Philips IntelliSite Pathology Solution with Ibex’s Galen AI-powered cancer diagnostics platform. The agreement then was aimed…
Breast cancer is on the rise worldwide, and research increasingly points toward the often-overlooked role of environmental chemicals like triclosan as key contributors to this escalating health crisis. Chemicals are pervasive in daily life, from the plastics used to store your food to the ingredients in your personal care products, and the pollutants filling your…
Photobiomodulation (PBM) therapy, also known as low-level laser therapy (LLLT), is a noninvasive therapeutic modality that utilizes light within specific wavelengths to stimulate beneficial biological processes in living tissues.1 This article explores the benefits and penetration depths of three distinct wavelengths: 660 nanometers (nm), 850 nm and 1,050 nm. These wavelengths have unique properties and…
Mercola proudly supports these charities and organizations. View All Charities & Organizations More About Mercola.com Disclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked. The information on this website is…
Navina, an AI-enabled clinical intelligence platform for primary care providers, announced the close of a $55 million Series C funding round, bringing its total raise to $100 million. Growth Equity at Goldman Sachs Alternatives led the round, with participation from existing investors Vertex Ventures Israel, ALIVE and Grove Ventures. WHAT IT DOES Navina offers providers,…
Evinova, a clinical trial technology company, is partnering with Quantum Leap Healthcare Collaborative (QLHC) to integrate Evinova’s remote patient monitoring (RPM) offering into I-SPY 2.2, a platform trial that provides a framework to study multiple novel therapeutic treatment arms for women with newly diagnosed, locally advanced breast cancer. A platform trial is a clinical trial…
Aura, an AI-enabled digital protection platform, announced it officially closed its Series G funding round, raising $140 million in equity and debt and bringing its valuation to $1.6 billion. The round initially closed in August 2024. Ten Eleven Ventures and Madrone Capital led the round, with participation from new investor AT&T Ventures. Existing investors General…
Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round. The round included new primary investors KIRKBI, M&G Investments and Lightrock with participation from existing shareholders. The company recently converted to a European stock corporation (SE). WHAT IT DOES Amboss helps medical students and professionals access…
